Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2025 09:07 ET | Source: KUEHN LAW, PLLC

Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm

Kuehn Law Encourages MRNS, OMIC, LBRDA, and VCSA Investors to Contact Law Firm
July 25, 2024 09:00 ET | Source: Portnoy Law

Marinus Pharmaceuticals Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm

LOS ANGELES, July 25, 2024 (GLOBE NEWSWIRE) -- Investors can contact the law firm at no cost to learn more about recovering their losses The Portnoy Law Firm advises Marinus Pharmaceuticals, Inc....
June 28, 2024 09:00 ET | Source: Portnoy Law

Marinus Pharmaceuticals Inc. Investors: Class action lawsuit filed on behalf of investors; the Portnoy Law Firm

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 28, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Marinus Pharmaceuticals, Inc....
June 20, 2024 13:30 ET | Source: Robbins LLP

MRNS Class Action Alert: Robbins LLP Reminds MRNS Stockholders About the Marinus Pharmaceuticals, Inc. Securities Fraud Class Action

Robbins LLP is Investigating Allegations Marinus Pharmaceuticals, Inc. (MRNS) Misled Investors Regarding the Viability of its Drug Candidate
June 11, 2024 07:18 ET | Source: Robbins LLP

MRNS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the Class Action Against Marinus Pharmaceuticals, Inc.

Robbins LLP is Investigating Allegations Marinus Pharmaceuticals, Inc. (MRNS) Misled Investors Regarding the Viability of its Drug Candidate
June 05, 2024 22:13 ET | Source: Robbins LLP

Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Marinus Pharmaceuticals, Inc. (MRNS)

Robbins LLP is Investigating Allegations that Marinus Pharmaceuticals, Inc. (MRNS) Misled Investors Regarding the Viability of its Drug Candidate